newsfilter
← Latest News
Business Wire·

Veracyte Announces First Prospective Validation Data for Biomarker Predicting Hormone Therapy Benefit in Men with Recurrent Prostate Cancer Will Be Presented at ASTRO 2025

Findings are among nine Decipher-focused abstracts being presented at annual conference Veracyte, Inc. (NASDAQ:VCYT), a leading genomic diagnostics company, announced today that the first prospective validation data